{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-006749","form_type":"8-K","ticker":"TLSI","cik":"0001826667","company_name":"TriSalus Life Sciences, Inc.","filed_at":"2024-01-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.772413+00:00","generated_at":"2026-06-06T18:28:22.026947+00:00","sec_items":["5.02"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"TriSalus Life Sciences grants CFO Sean Murphy option for 125,000 shares at $9.28","bullets":["Granted on Jan 24, 2024, under the 2023 Equity Incentive Plan.","Exercise price of $9.28 per share, equal to grant-date market price.","Vests 25% on first anniversary, remaining 75% in 36 equal monthly installments.","Contingent on Mr. Murphy's continuous service through each vesting date.","Award recognizes CFO's 2023 performance and aligns long-term incentives."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-006749","json":"https://secwatch.observer/filing/0001104659-24-006749.json","markdown":"https://secwatch.observer/filing/0001104659-24-006749.md","text":"https://secwatch.observer/filing/0001104659-24-006749.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1826667/000110465924006749/0001104659-24-006749-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1826667/000110465924006749/tm244105d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T18:28:22.026947+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}